Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A review on the pathophysiology of asthma remission
Orestes A. Carpaij, Janette K. Burgess, Huib A.M. Kerstjens, et al.
Pharmacology & Therapeutics (2019) Vol. 201, pp. 8-24
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Asthma remission: what is it and how can it be achieved?
Dennis Thomas, Vanessa M. McDonald, Ian Pavord, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 5, pp. 2102583-2102583
Open Access | Times Cited: 150
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus
Giorgio Walter Canonica, Francesco Blasi, Giovanna Elisiana Carpagnano, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 12, pp. 3629-3637
Open Access | Times Cited: 62
Drug nanodelivery systems based on natural polysaccharides against different diseases
Abdur Rehman, Seid Mahdi Jafari, Qunyi Tong, et al.
Advances in Colloid and Interface Science (2020) Vol. 284, pp. 102251-102251
Closed Access | Times Cited: 108
Identifying Super-Responders: a Review of the Road to Asthma Remission
Samuel Mailhot-Larouche, C.A. Celis-Preciado, Liam G. Heaney, et al.
Annals of Allergy Asthma & Immunology (2024)
Open Access | Times Cited: 7
Clinical remission in severe asthma: lights and shadows on an ambitious goal
Corrado Pelaia, Eleonora Zannoni, Giovanni Paoletti, et al.
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 4, pp. 230-236
Closed Access | Times Cited: 5
SANI clinical remission definition: a useful tool in severe asthma management
Giorgio Walter Canonica, Diego Bagnasco, Benedetta Bondi, et al.
Journal of Asthma (2024) Vol. 61, Iss. 12, pp. 1593-1600
Open Access | Times Cited: 5
Fucoxanthin Ameliorates Oxidative Stress and Airway Inflammation in Tracheal Epithelial Cells and Asthmatic Mice
Shu-Ju Wu, Chian‐Jiun Liou, Ya-Ling Chen, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1311-1311
Open Access | Times Cited: 28
An Updated Comprehensive Review of Plants and Herbal Compounds with Antiasthmatic Effect
Mohammad Amin Rajizadeh, Hamid Najafipour, Mohammad Abbas Bejeshk
Evidence-based Complementary and Alternative Medicine (2024) Vol. 2024, pp. 1-36
Open Access | Times Cited: 4
PI3K Pathway Activation in Severe Asthma is Linked to Steroid Insensitivity and Adverse Outcomes
Sekiko Uehara, Keita Hirai, Toshihiro Shirai, et al.
Journal of Allergy and Clinical Immunology Global (2025) Vol. 4, Iss. 2, pp. 100439-100439
Open Access
Younger severe asthma patients with interleukin 4 (CC variant) and dupilumab treatment are more likely to achieve clinical remission
Mona Al‐Ahmad, Asmaa Ali, Wafaa Talat
BMC Pulmonary Medicine (2025) Vol. 25, Iss. 1
Open Access
Investigation of the Molecular Mechanism of Asthma in Meishan Pigs Using Multi-Omics Analysis
Weilong Tu, Hongyang Wang, Yingying Zhang, et al.
Animals (2025) Vol. 15, Iss. 2, pp. 200-200
Open Access
Early clinical remission and its role in lung function decline and exacerbation in adult Korean patients with asthma
Eunhye Bae, Hyun Jun Park, Heemoon Park, et al.
Thorax (2025), pp. thorax-222679
Closed Access
Airway epithelial cells as drivers of severe asthma pathogenesis
Delbert R. Dorscheid, Gail M. Gauvreau, Steve N. Georas, et al.
Mucosal Immunology (2025)
Open Access
Challenges and Opportunities in Achieving Asthma Remission
Elena Cojocaru, Raluca Ioana Arcana, Steluţa Radu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2835-2835
Open Access
Interleukin 4 gene polymorphism (−589C/T) and the risk of asthma: a meta-analysis and met-regression based on 55 studies
Ahmad Kousha, Armita Mahdavi Gorabi, Mehdi Forouzesh, et al.
BMC Immunology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 27
Defining response to therapy with biologics in severe asthma: from global evaluation to super response and remission
Andriana Ι. Papaioannou, Evangelia Fouka, Κonstantinos Bartziokas, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 6, pp. 481-493
Closed Access | Times Cited: 8
Long noncoding RNA LINC-PINT retards the abnormal growth of airway smooth muscle cells via regulating the microRNA-26a-5p/PTEN axis in asthma
Pei Gao, Ying Ding, Bingru Yin, et al.
International Immunopharmacology (2021) Vol. 99, pp. 107997-107997
Closed Access | Times Cited: 16
Age-Dependent Reduction in Asthmatic Pathology through Reprogramming of Postviral Inflammatory Responses
Guy Hazan, Anna Eubanks, Carrie Gierasch, et al.
The Journal of Immunology (2022) Vol. 208, Iss. 6, pp. 1467-1482
Open Access | Times Cited: 12
The epithelial era of asthma research: knowledge gaps and future direction for patient care
Christopher E. Brightling, Gianni Marone, Helena Aegerter, et al.
European Respiratory Review (2024) Vol. 33, Iss. 174, pp. 240221-240221
Open Access | Times Cited: 2
Genetic deletion of the Tas2r143/Tas2r135/Tas2r126 cluster reveals that TAS2Rs may not mediate bitter tastant‐induced bronchodilation
Ping Lü, Mai K. ElMallah, Zeyu Liu, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 9, pp. 6407-6423
Open Access | Times Cited: 15
Can asthma biologics change the course of disease and induce drug-free remission?
Lauren Cohn
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 1, pp. 59-61
Open Access | Times Cited: 10
Accelerated decline in lung function in adults with a history of remitted childhood asthma
Shin‐ichiro Miura, Hiroshi Iwamoto, Keitaro Omori, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 1, pp. 2100305-2100305
Open Access | Times Cited: 14
Variables predicting clinical remission among adults with severe asthma treated with biologic agents
Selma Yeşilkaya, Kurtuluş Aksu, Gürgün Tuğçe Vural Solak, et al.
European Annals of Allergy and Clinical Immunology (2023) Vol. 56, Iss. 05, pp. 219-219
Open Access | Times Cited: 5
Inhibition of soluble epoxide hydrolase attenuates airway remodeling in a chronic asthma model
Junxia Jiang, Yan Guan, Huijuan Shen, et al.
European Journal of Pharmacology (2019) Vol. 868, pp. 172874-172874
Closed Access | Times Cited: 14
Effect of the COVID-19 Lockdown on Asthma Biological Rhythms
Guy Hazan, Carolyn Fox, Elise Eiden, et al.
Journal of Biological Rhythms (2022) Vol. 37, Iss. 2, pp. 152-163
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top